Welcome to our dedicated page for IPERIONX SEC filings (Ticker: IPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on IPERIONX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into IPERIONX's regulatory disclosures and financial reporting.
IperionX Limited (IPX) filed its FY2025 Form 20‑F, highlighting continued scale-up of U.S. titanium manufacturing alongside operating losses. The company reported a net loss of $35.3 million for fiscal 2025 versus $21.8 million in 2024, with cash reserves of $54.8 million and net assets of $92.4 million at June 30, 2025.
IperionX has commissioned commercial operations at its Virginia Titanium Manufacturing Campus at 125 metric tons per year, and outlined plans to scale to 1,400 metric tons per year in 2027. The company also notes the U.S. government currently holds title to certain Titanium Production Facility assets acquired with federal funds, with a possible transfer after January 30, 2027 subject to conditions.
Shares outstanding were 319,927,854 ordinary shares as of June 30, 2025. Management states prior internal control material weaknesses were remediated as of June 30, 2025. The filing reiterates risks around financing needs, scaling production, market demand for titanium, permitting and compliance, and reliance on government-supported assets.
IperionX Limited (NASDAQ: IPX) submitted a Form 6-K on June 27, 2025. The filing is procedural and contains no operating or financial results. Two exhibits are listed:
- Exhibit 99.1 – Notice of General Meeting
- Exhibit 99.2 – Results of Meeting